Latin America Transaminase Test Market Size & Outlook
Related Markets
Latin America transaminase test market highlights
- The Latin America transaminase test market generated a revenue of USD 267.7 million in 2024.
- The market is expected to grow at a CAGR of 6.6% from 2025 to 2033.
- In terms of segment, automated analyzers was the largest revenue generating technology in 2024.
- Paper-Based / Lab-on-a-Chip Platforms is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2025 to 2033.
Latin America data book summary
| Market revenue in 2024 | USD 267.7 million |
| Market revenue in 2033 | USD 471.0 million |
| Growth rate | 6.6% (CAGR from 2025 to 2033) |
| Largest segment | Automated analyzers |
| Fastest growing segment | Paper-Based / Lab-on-a-Chip Platforms |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Automated Analyzers, Semi-Automated & Manual Systems, Point-of-Care (POC) Devices, Paper-Based / Lab-on-a-Chip Platforms |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens Healthineers AG ADR, Danaher Corp, Randox, Bruker Corp, Horiba Ltd, Alpha Laboratories, Labcorp Holdings Inc, Bio-Rad Laboratories Inc, BioMerieux SA |
Other key industry trends
- In terms of revenue, Latin America region accounted for 6.5% of the global transaminase test market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,052.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transaminase Test Market Scope
Transaminase Test Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Alpha Laboratories | View profile | 11-50 | Eastleigh, Hampshire, United Kingdom, Europe | https://www.alphalabs.co.uk |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | http://www.randox.com |
| Bruker Corp | View profile | 9707 | 40 Manning Road, Billerica, MA, United States, 01821 | https://www.bruker.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Horiba Ltd | View profile | 8665 | 2, Miyanohigashi-cho, Kisshoin, Minami-ku, Kyoto, Japan, 601-8510 | http://www.horiba.co.jp |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Latin America transaminase test market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transaminase test market will help companies and investors design strategic landscapes.
Automated analyzers was the largest segment with a revenue share of 55.29% in 2024. Horizon Databook has segmented the Latin America transaminase test market based on automated analyzers, semi-automated & manual systems, point-of-care (poc) devices, paper-based / lab-on-a-chip platforms covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Latin America transaminase test market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America transaminase test market databook
-
Our clientele includes a mix of transaminase test market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America transaminase test market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America transaminase test market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America transaminase test market size, by country, 2021-2033 (US$M)
Latin America Transaminase Test Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
